News

Find the latest news from CMCiB. For more news at IGTP, please see its website.

La Marató de 3Cat funds three IGTP projects to improve cancer diagnosis and treatment

IGTP coordinates one of the selected projects and is involved in two others, focusing on the identification of biomarkers, treatment resistance and anti-tumour immune responses. Together, the three initiatives have received nearly €1.1 million in funding.

Artificial intelligence and biomarkers take centre stage at a new IGTP-EATRIS event

IGTP held a new event in collaboration with EATRIS, the European infrastructure for translational medicine, focusing this year on the role of artificial intelligence in biomarker research and precision medicine.

IGTP project receives €49,000 from CaixaImpulse to advance a precision cell therapy for multiple sclerosis

A project led by Federico Fondelli, researcher at the IGTP, has been selected in the 2026 CaixaImpulse Health Innovation call promoted by the "la Caixa" Foundation. The project will receive €49,000 to advance the development of a new cell therapy strategy aimed at specifically restoring the immune system's tolerance to myelin in people with multiple sclerosis.

The CMCiB expands its housing capacity and upgrades infrastructure for biomedical research

The CMCiB, strategic project of IGTP, continues to strengthen its capacity to support biomedical research with the opening of a new rodent housing facility and the upgrading of part of its animal housing systems. This initiative increases the centre's capacity to support researchers, strengthens safety and biocontainment, improves animal welfare and provides more efficient working environments for health research projects.

IGTP explores new opportunities for collaboration with Türkiye's research and innovation ecosystem

IGTP welcomed a delegation of research organisations, universities and innovation stakeholders from Türkiye as part of a health-focused technical mission to Spain. The visit provided an opportunity to share expertise, explore potential collaborations and strengthen connections for future European research projects.

'Consorci Oncològic Integral Nord Catalunya' launched: a strategic alliance to bring european excellence in cancer care closer to nearly two million people

Six leading institutions are joining forces across healthcare, research, education and innovation to create one of southern Europe's strongest cancer ecosystems. The new Consorci Oncològic Integral Nord Catalunya aims to achieve European certification as a Comprehensive Cancer Consortium and join the European network of excellence in oncology.